{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T18:13:55Z","timestamp":1788718435672,"version":"build-2803163510"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T00:00:00Z","timestamp":1624233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012052","name":"Insurance and Care NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Thoracic cancers pose a significant global health burden. Immune checkpoint blockade therapies have improved treatment outcomes, but durable responses remain limited. Understanding how the host immune system interacts with a developing tumor is essential for the rational development of improved treatments for thoracic malignancies. Recent technical advances have improved our understanding of the mutational burden of cancer cells and changes in cancer-specific gene expression, providing a detailed understanding of the complex biology underpinning tumor-host interactions. While there has been much focus on the genetic alterations associated with cancer cells and how they may impact treatment outcomes, how host genetics affects cancer development is also critical and will greatly determine treatment response. Genome-wide association studies (GWAS) have identified genetic variants associated with cancer predisposition. This approach has successfully identified host genetic risk factors associated with common thoracic cancers like lung cancer, but is less effective for rare cancers like malignant mesothelioma. To assess how host genetics impacts rare thoracic cancers, we used the Collaborative Cross (CC); a powerful murine genetic resource designed to maximize genetic diversity and rapidly identify genes associated with any biological trait. We are using the CC in conjunction with our asbestos-induced MexTAg mouse model, to identify host genes associated with mesothelioma development. Once genes that moderate tumor development and progression are known, human homologues can be identified and human datasets interrogated to validate their association with disease outcome. Furthermore, our CC\u2212MexTAg animal model enables in-depth study of the tumor microenvironment, allowing the correlation of immune cell infiltration and gene expression signatures with disease development. This strategy provides a detailed picture of the underlying biological pathways associated with mesothelioma susceptibility and progression; knowledge that is crucial for the rational development of new diagnostic and therapeutic strategies. Here we discuss the influence of host genetics on developing an effective immune response to thoracic cancers. We highlight current knowledge gaps, and with a focus on mesothelioma, describe the development and application of the CC-MexTAg to overcome limitations and illustrate how the knowledge gained from this unique study will inform the rational design of future treatments of mesothelioma. <\/jats:p>","DOI":"10.3389\/fonc.2021.679609","type":"journal-article","created":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T09:17:57Z","timestamp":1624267077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["How to Better Understand the Influence of Host Genetics on Developing an Effective Immune Response to Thoracic Cancers"],"prefix":"10.3389","volume":"11","author":[{"given":"Kiarash","family":"Behrouzfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E.","family":"Mutsaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Morahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.02.047","article-title":"Rare Thoracic Cancers, Including Peritoneum Mesothelioma","volume":"48","author":"Siesling","year":"2012","journal-title":"Eur J Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.annpat.2016.12.009","article-title":"Efficacy of PD-1\/PD-L1 Immune Checkpoint Inhibitors and PD-L1 Testing in Thoracic Cancers","volume":"8","author":"Duruisseaux","year":"2017","journal-title":"Ann Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.05.027","article-title":"Moving Immune Checkpoint Blockade in Thoracic Tumors Beyond NSCLC","volume":"11","author":"Facchinetti","year":"2016","journal-title":"J Thorac Oncol"},{"key":"B4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-319-53082-6_9","article-title":"The Immunobiology of Cancer: From Tumor Escape to Cancer Immunoediting Towards Immunotherapy in Gynecologic Oncology","volume-title":"Molecular Oncology: Underlying Mechanisms and Translational Advancements","author":"Gasparri","year":"2017"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29098","article-title":"Small Cell Lung Cancer: Where do We Go From Here","volume":"121","author":"Byers","year":"2015","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e1278330","DOI":"10.1080\/2162402X.2016.1278330","article-title":"Integrated Analysis of Somatic Mutations and Immune Microenvironment in Malignant Pleural Mesothelioma","volume":"6","author":"Kiyotani","year":"2017","journal-title":"Oncoimmunology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2020.01.004","article-title":"Mouse Systems Genetics as a Prelude to Precision Medicine","volume":"36","author":"Li","year":"2020","journal-title":"Trends Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.02.034","article-title":"Immunity and Malignant Mesothelioma: From Mesothelial Cell Damage to Tumor Development and Immune Response-Based Therapies","volume":"322","author":"Izzi","year":"2012","journal-title":"Cancer Lett"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.3390\/cancers12061535","article-title":"Tp53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival","volume":"12","author":"Freudenstein","year":"2020","journal-title":"Cancers"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, Activity, and Immune Correlates of Anti\u2013PD-1 Antibody in Cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4161\/onci.19531","article-title":"A Genetic Inference on Cancer Immune Responsiveness","volume":"1","author":"Wang","year":"2012","journal-title":"Oncoimmunology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"19393","DOI":"10.18632\/oncotarget.5107","article-title":"The Anticancer Immune Response of anti-PD-1\/PD-L1 and the Genetic Determinants of Response to anti-PD-1\/PD-L1 Antibodies in Cancer Patients","volume":"6","author":"Sui","year":"2015","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1804506115","article-title":"Germline Genetic Polymorphisms Influence Tumor Gene Expression and Immune Cell Infiltration","volume":"115","author":"Lim","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11883","article-title":"Rare Disruptive Mutations and Their Contribution to the Heritable Risk of Colorectal Cancer","volume":"7","author":"Chubb","year":"2016","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","article-title":"Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer","volume":"35","author":"Yurgelun","year":"2017","journal-title":"J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.01.018","article-title":"Inherited DNA-Repair Defects in Colorectal Cancer","volume":"102","author":"AlDubayan","year":"2018","journal-title":"Am J Hum Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-Wide Polygenic Scores for Common Diseases Identify Individuals With Risk Equivalent to Monogenic Mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nrc.2017.82","article-title":"Genome-Wide Association Studies of Cancer: Current Insights and Future Perspectives","volume":"17","author":"Sud","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1450","article-title":"Genetic Predisposition to Cancer\u2014Insights From Population Genetics","volume":"5","author":"Frank","year":"2004","journal-title":"Nat Rev Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4255","DOI":"10.1200\/JCO.2009.25.7816","article-title":"Genome-Wide Association Studies of Cancer","volume":"28","author":"Stadler","year":"2010","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3002","article-title":"Rare Variants of Large Effect in BRCA2 and CHEK2 Affect Risk of Lung Cancer","volume":"46","author":"Wang","year":"2014","journal-title":"Nat Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds334","article-title":"Influence of Common Genetic Variation on Lung Cancer Risk: Meta-Analysis of 14 900 Cases and 29 485 Controls","volume":"21","author":"Timofeeva","year":"2012","journal-title":"Hum Mol Genet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3892","article-title":"Large-Scale Association Analysis Identifies New Lung Cancer Susceptibility Loci and Heterogeneity in Genetic Susceptibility Across Histological Subtypes","volume":"49","author":"McKay","year":"2017","journal-title":"Nat Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00176811","article-title":"CHRNA3 Genotype, Nicotine Dependence, Lung Function and Disease in the General Population","volume":"40","author":"Kaur-Knudsen","year":"2012","journal-title":"Eur Respir J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/ahg.12264","article-title":"Chrna3 rs1051730 and CHRNA5 rs16969968 Polymorphisms Are Associated With Heavy Smoking, Lung Cancer, and Chronic Obstructive Pulmonary Disease in a Mexican Population","volume":"82","author":"P\u00e9rez-Morales","year":"2018","journal-title":"Ann Hum Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp287","article-title":"Role of 5p15. 33 (Tert-CLPTM1L), 6p21. 33 and 15q25. 1 (Chrna5-CHRNA3) Variation and Lung Cancer Risk in Never-Smokers","volume":"31","author":"Wang","year":"2010","journal-title":"Carcinogenesis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ng.667","article-title":"Variation in TP63 Is Associated With Lung Adenocarcinoma Susceptibility in Japanese and Korean Populations","volume":"42","author":"Miki","year":"2010","journal-title":"Nat Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30144-4","article-title":"Identification of Risk Loci and a Polygenic Risk Score for Lung Cancer: A Large-Scale Prospective Cohort Study in Chinese Populations","volume":"7","author":"Dai","year":"2019","journal-title":"Lancet Respir Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0794","article-title":"A Decade of GWAS Results in Lung Cancer","volume":"27","author":"Boss\u00e9","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"djv279","DOI":"10.1093\/jnci\/djv279","article-title":"Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types","volume":"107","author":"Sampson","year":"2015","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"B31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and Heritable Factors in the Causation of Cancer\u2014Analyses of Cohorts of Twins From Sweden, Denmark, and Finland","volume":"343","author":"Lichtenstein","year":"2000","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2013.04.018","article-title":"A Genome-Wide Association Study for Malignant Mesothelioma Risk","volume":"82","author":"Cadby","year":"2013","journal-title":"Lung Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgv097","article-title":"Gene\u2013Asbestos Interaction in Malignant Pleural Mesothelioma Susceptibility","volume":"36","author":"Tunesi","year":"2015","journal-title":"Carcinogenesis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e61253","DOI":"10.1371\/journal.pone.0061253","article-title":"Genetic Variants Associated With Increased Risk of Malignant Pleural Mesothelioma: A Genome-Wide Association Study","volume":"8","author":"Matullo","year":"2013","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2006.02.005","article-title":"Polymorphisms in DNA Repair Genes as Risk Factors for Asbestos-Related Malignant Mesothelioma in a General Population Study","volume":"599","author":"Dianzani","year":"2006","journal-title":"Mutat Res\/Fundam Mol Mech Mutagen"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 Mutations Predispose to Malignant Mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 Cancer Syndrome: Malignant Mesothelioma, Uveal and Cutaneous Melanoma, and Mbaits","volume":"10","author":"Carbone","year":"2012","journal-title":"J Trans Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181f209b9","article-title":"Thymic Tumors: Relevant Molecular Data in the Clinic","volume":"5","author":"Girard","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7336","DOI":"10.1038\/srep07336","article-title":"Mutations of Epigenetic Regulatory Genes Are Common in Thymic Carcinomas","volume":"4","author":"Wang","year":"2014","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-14638-w","article-title":"Endogenous Topoisomerase II-mediated DNA Breaks Drive Thymic Cancer Predisposition Linked to ATM Deficiency","volume":"11","author":"\u00c1lvarez-Quil\u00f3n","year":"2020","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.271","article-title":"The Tumor Microenvironment and Its Role in Promoting Tumor Growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/0008-5472.CAN-07-0988","article-title":"A Macrophage Gene Expression Signature Defines a Field Effect in the Lung Tumor Microenvironment","volume":"68","author":"Stearman","year":"2008","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/modpathol.2014.81","article-title":"Etiologic Field Effect: Reappraisal of the Field Effect Concept in Cancer Predisposition and Progression","volume":"28","author":"Lochhead","year":"2015","journal-title":"Modern Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa6806","article-title":"Tumor Evolution. High Burden and Pervasive Positive Selection of Somatic Mutations in Normal Human Skin","volume":"348","author":"Martincorena","year":"2015","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1616556114","article-title":"Contribution of Epigenetic Mechanisms to Variation in Cancer Risk Among Tissues","volume":"114","author":"Klutstein","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3390\/cancers11121911","article-title":"Immunological Effects of Epigenetic Modifiers","volume":"11","author":"Bezu","year":"2019","journal-title":"Cancers"},{"key":"B48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1593\/neo.13280","article-title":"Methylation Profiling Defines an Extensive Field Defect in Histologically Normal Prostate Tissues Associated With Prostate Cancer","volume":"15","author":"Yang","year":"2013","journal-title":"Neoplasia"},{"key":"B49","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13148-019-0771-5","article-title":"Validation of an Epigenetic Field of Susceptibility to Detect Significant Prostate Cancer From non-Tumor Biopsies","volume":"11","author":"Yang","year":"2019","journal-title":"Clin Epigenet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.7150\/jca.27457","article-title":"Epigenetic Field Cancerization in Gastric Cancer: microRNAs as Promising Biomarkers","volume":"10","author":"Pereira","year":"2019","journal-title":"J Cancer"},{"key":"B51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13148-017-0352-4","article-title":"Analysis of the DNA Methylation Level of Cancer-Related Genes in Colorectal Cancer and the Surrounding Normal Mucosa","volume":"9","author":"Sugai","year":"2017","journal-title":"Clin Epigenet"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/geaa022","article-title":"Frequent DNA Methylation Changes in Cancerous and Noncancerous Lung Tissues From Smokers With non-Small Cell Lung Cancer","volume":"35","author":"Daniunaite","year":"2020","journal-title":"Mutagenesis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31351","article-title":"Interaction Analysis Between Germline Susceptibility Loci and Somatic Alterations in Lung Cancer","volume":"143","author":"Wang","year":"2018","journal-title":"Int J Cancer"},{"key":"B54","article-title":"Potential Therapeutic Targets in ARID1A-mutated Cancers","volume-title":"Expert Opin Ther Targets","author":"Bitler","year":"2015"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-020-00208-9","article-title":"Subunits of ARID1 Serve as Novel Biomarkers for the Sensitivity to Immune Checkpoint Inhibitors and Prognosis of Advanced non-Small Cell Lung Cancer","volume":"26","author":"Sun","year":"2020","journal-title":"Mol Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.21037\/tlcr.2019.11.15","article-title":"Mesothelioma Developing in Carriers of Inherited Genetic Mutations","volume":"9","author":"Yoshikawa","year":"2020","journal-title":"Trans Lung Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000336","article-title":"Genetic Associations of T Cell Cancer Immune Response-Related Genes With T Cell Phenotypes and Clinical Outcomes of Early-Stage Lung Cancer","volume":"8","author":"Wang","year":"2020","journal-title":"J ImmunoTher Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13148-017-0354-2","article-title":"Epigenetic Modifications of the Immune-Checkpoint Genes CTLA4 and PDCD1 in non-Small Cell Lung Cancer Results in Increased Expression","volume":"9","author":"Marwitz","year":"2017","journal-title":"Clin Epigenet"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acr.2019.03.007","article-title":"Can CpG Methylation Serve as Surrogate Markers for Immune Infiltration in Cancer","volume":"143","author":"Bacolod","year":"2019","journal-title":"Adv Cancer Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-02940-w","article-title":"P53-Regulated miR-320a Targets PDL1 and Is Downregulated in Malignant Mesothelioma","volume":"11","author":"Costa","year":"2020","journal-title":"Cell Death Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000299","article-title":"Alterations of the Immune System in Thymic Malignancies","volume":"9","author":"Weksler","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11864-019-0661-2","article-title":"Paraneoplastic and Therapy-Related Immune Complications in Thymic Malignancies","volume":"20","author":"Lippner","year":"2019","journal-title":"Curr Treat Options Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2020.08.005","article-title":"The Molecular Basis of Malignant Pleural Mesothelioma","volume":"30","author":"Wadowski","year":"2020","journal-title":"Thorac Surg Clin"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1181","article-title":"Integrative Molecular Characterization of Malignant Pleural Mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3520","article-title":"Comprehensive Genomic Analysis of Malignant Pleural Mesothelioma Identifies Recurrent Mutations, Gene Fusions and Splicing Alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41467-019-09307-6","article-title":"Dissecting Heterogeneity in Malignant Pleural Mesothelioma Through Histo-Molecular Gradients for Clinical Applications","volume":"10","author":"Blum","year":"2019","journal-title":"Nat Commun"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1610322","DOI":"10.1080\/23723556.2019.1610322","article-title":"Unraveling the Cellular Heterogeneity of Malignant Pleural Mesothelioma Through a Deconvolution Approach","volume":"6","author":"Blum","year":"2019","journal-title":"Mol Cell Oncol"},{"key":"B68","doi-asserted-by":"crossref","DOI":"10.1007\/s00438-020-01647-z","article-title":"GWAS in Cancer: Progress and Challenges","volume":"295","author":"Liang","year":"2020","journal-title":"Mol Genet Genomics"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2564","article-title":"GWAS Meta-Analysis and Replication Identifies Three New Susceptibility Loci for Ovarian Cancer","volume":"45","author":"Pharoah","year":"2013","journal-title":"Nat Genet"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-170159","article-title":"Bladder Cancer Genetic Susceptibility. A Systematic Review","volume":"4","author":"de Maturana","year":"2018","journal-title":"Bladder Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2009.09.012","article-title":"Next Generation Disparities in Human Genomics: Concerns and Remedies","volume":"25","author":"Need","year":"2009","journal-title":"Trends Genet"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1101\/gr.094615.109","article-title":"Instrumenting the Health Care Enterprise for Discovery Research in the Genomic Era","volume":"19","author":"Murphy","year":"2009","journal-title":"Genome Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2009.12.008","article-title":"Beyond Genome-Wide Association Studies: Genetic Heterogeneity and Individual Predisposition to Cancer","volume":"26","author":"Galvan","year":"2010","journal-title":"Trends Genet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-29634-w","article-title":"Using Whole Genome Scores to Compare Three Clinical Phenotyping Methods in Complex Diseases","volume":"8","author":"Song","year":"2018","journal-title":"Sci Rep"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0044","article-title":"Mouse Models for Cancer Immunotherapy Research","volume":"8","author":"Olson","year":"2018","journal-title":"Cancer Discov"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197103000-00012","article-title":"Some Aspects of Immunological Tolerance Investigated by Parent to F1 Hybrid Parabiosis in Mice","volume":"11","author":"Nisbet","year":"1971","journal-title":"Transplantation"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3335","article-title":"Genome-Wide Association Studies in Mice","volume":"13","author":"Flint","year":"2012","journal-title":"Nat Rev Genet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1017\/S0016672300032705","article-title":"At Least Four Genes and Sex are Associated With Susceptibility to Urethane-Induced Pulmonary Adenomas in Mice","volume":"64","author":"Festing","year":"1994","journal-title":"Genet Res"},{"key":"B79","article-title":"Genetic Mapping of Lung Cancer Modifier Loci Specifically Affecting Tumor Initiation and Progression","volume":"57","author":"Manenti","year":"1997","journal-title":"Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205886","article-title":"Linkage Disequilibrium Mapping of Novel Lung Tumor Susceptibility Quantitative Trait Loci in Mice","volume":"21","author":"Wang","year":"2002","journal-title":"Oncogene"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)02406-3","article-title":"Gene Mapping of SEZ Group Genes and Determination of Pentylenetetrazol Susceptible Quantitative Trait Loci in the Mouse Chromosome","volume":"857","author":"Wakana","year":"2000","journal-title":"Brain Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-004-2380-6","article-title":"Genetic Structure of the LXS Panel of Recombinant Inbred Mouse Strains: A Powerful Resource for Complex Trait Analysis","volume":"15","author":"Williams","year":"2004","journal-title":"Mamm Genome"},{"key":"B83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/ilar.52.1.24","article-title":"The Collaborative Cross: A Recombinant Inbred Mouse Population for the Systems Genetic Era","volume":"52","author":"Threadgill","year":"2011","journal-title":"ILAR J"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-007-9045-1","article-title":"The Polymorphism Architecture of Mouse Genetic Resources Elucidated Using Genome-Wide Resequencing Data: Implications for QTL Discovery and Systems Genetics","volume":"18","author":"Roberts","year":"2007","journal-title":"Mamm Genome"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/ng1104-1133","article-title":"The Collaborative Cross, a Community Resource for the Genetic Analysis of Complex Traits","volume":"36","author":"Churchill","year":"2004","journal-title":"Nat Genet"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-008-9134-9","article-title":"Establishment of \u201cThe Gene Mine\u201d: A Resource for Rapid Identification of Complex Trait Genes","volume":"19","author":"Morahan","year":"2008","journal-title":"Mamm Genome"},{"key":"B87","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1534\/genetics.114.163014","article-title":"Rapid Identification of Major-Effect Genes Using the Collaborative Cross","volume":"198","author":"Ram","year":"2014","journal-title":"Genetics"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.227","article-title":"Melanoma Susceptibility as a Complex Trait: Genetic Variation Controls All Stages of Tumor Progression","volume":"34","author":"Ferguson","year":"2015","journal-title":"Oncogene"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e61848","DOI":"10.1371\/journal.pone.0061848","article-title":"Germline Genetic Variation Modulates Tumor Progression and Metastasis in a Mouse Model of Neuroendocrine Prostate Carcinoma","volume":"8","author":"Patel","year":"2013","journal-title":"PLoS One"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05137-0","article-title":"E2f8 and Dlg2 Genes Have Independent Effects on Impaired Insulin Secretion Associated With Hyperglycaemia","volume":"63","author":"Yang","year":"2020","journal-title":"Diabetologia"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00288","article-title":"Advanced Genetic Approaches in Discovery and Characterization of Genes Involved With Osteoporosis in Mouse and Human","volume":"10","author":"Yuan","year":"2019","journal-title":"Front Genet"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.14-16289","article-title":"Characterization of Retinal Vascular and Neural Damage in a Novel Model of Diabetic Retinopathy","volume":"56","author":"Weerasekera","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42424","article-title":"Different Genetic Mechanisms Mediate Spontaneous Versus UVR-Induced Malignant Melanoma","volume":"8","author":"Ferguson","year":"2019","journal-title":"Elife"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12487","article-title":"A Mutation in the Cdon Gene Potentiates Congenital Nevus Development Mediated by NRAS(Q61K)","volume":"29","author":"Chitsazan","year":"2016","journal-title":"Pigment Cell Melanom Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jid.2017.10.032","article-title":"Keratinocyte Sonic Hedgehog Upregulation Drives the Development of Giant Congenital Nevi Via Paracrine Endothelin-1 Secretion","volume":"138","author":"Chitsazan","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B96","doi-asserted-by":"crossref","DOI":"10.1016\/S0065-230X(10)06004-5","article-title":"Genetically Engineered Mouse Models in Cancer Research","volume-title":"Adv Cancer Res","author":"Walrath","year":"2010"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.029462","article-title":"Generating Mouse Models for Biomedical Research: Technological Advances","volume":"12","author":"Gurumurthy","year":"2019","journal-title":"Dis Models Mech"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606857","article-title":"Genetically Engineered Mouse Models in Oncology Research and Cancer Medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/35074129","article-title":"Somatic Activation of the K-ras Oncogene Causes Early Onset Lung Cancer in Mice","volume":"410","author":"Johnson","year":"2001","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2001","article-title":"miRNA-34 Prevents Cancer Initiation and Progression in a Therapeutically Resistant K-ras and p53-induced Mouse Model of Lung Adenocarcinoma","volume":"72","author":"Kasinski","year":"2012","journal-title":"Cancer Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4556","article-title":"TP53 and KRAS2 Mutations in Plasma DNA of Healthy Subjects and Subsequent Cancer Occurrence: A Prospective Study","volume":"66","author":"Gormally","year":"2006","journal-title":"Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30591","article-title":"KRAS Mutation Coupled With p53 Loss is Sufficient to Induce Ovarian Carcinosarcomas in Mice","volume":"140","author":"Tang","year":"2017","journal-title":"Int J Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00101","article-title":"Preclinical Models of Malignant Mesothelioma","volume":"10","author":"Testa","year":"2020","journal-title":"Front Oncol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-4093","article-title":"Inactivation of Bap1 Cooperates With Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models","volume":"79","author":"Kukuyan","year":"2019","journal-title":"Cancer Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206593","article-title":"Hemizygosity of Nf2 is Associated With Increased Susceptibility to Asbestos-Induced Peritoneal Tumours","volume":"22","author":"Fleury-Feith","year":"2003","journal-title":"Oncogene"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/onc.2015.243","article-title":"Minimal Asbestos Exposure in Germline BAP1 Heterozygous Mice Is Associated With Deregulated Inflammatory Response and Increased Risk of Mesothelioma","volume":"35","author":"Napolitano","year":"2016","journal-title":"Oncogene"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216602","article-title":"Use of Preclinical Models for Malignant Pleural Mesothelioma","author":"Shamseddin","year":"2021","journal-title":"Thorax"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-3371","article-title":"Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence From Mouse Models Carrying Heterozygous Germline Bap1 Mutations","volume":"76","author":"Kadariya","year":"2016","journal-title":"Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191257","article-title":"Combined Deletion of Bap1, Nf2, and Cdkn2ab Causes Rapid Onset of Malignant Mesothelioma in Mice","volume":"217","author":"Badhai","year":"2020","journal-title":"J Exp Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.01.030","article-title":"A Conditional Mouse Model for Malignant Mesothelioma","volume":"13","author":"Jongsma","year":"2008","journal-title":"Cancer Cell"},{"key":"B111","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2217\/lmt.14.27","article-title":"Mouse Models of Mesothelioma: Strengths, Limitations and Clinical Translation","volume":"3","author":"Robinson","year":"2014","journal-title":"Lung Cancer Manage"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1328","article-title":"Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.16.154815","article-title":"Asbestos Accelerates Disease Onset in a Genetic Model of Malignant Pleural Mesothelioma","author":"Farahmand","year":"2020","journal-title":"BioRxiv"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4668","article-title":"A Novel SV40 Tag Transgenic Model of Asbestos-Induced Mesothelioma: Malignant Transformation is Dose Dependent","volume":"66","author":"Robinson","year":"2006","journal-title":"Cancer Res"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.08.015","article-title":"MexTAg Mice Exposed to Asbestos Develop Cancer That Faithfully Replicates Key Features of the Pathogenesis of Human Mesothelioma","volume":"47","author":"Robinson","year":"2011","journal-title":"Eur J Cancer"},{"key":"B116","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1186\/s12885-015-1953-y","article-title":"Consistent Gene Expression Profiles in MexTAg Transgenic Mouse and Wild Type Mouse Asbestos-Induced Mesothelioma","volume":"15","author":"Robinson","year":"2015","journal-title":"BMC Cancer"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/nm0897-913","article-title":"The Retinoblastoma Gene Family pRb\/p105, p107, pRb2\/p130 and Simian Virus-40 Large T-Antigen in Human Mesotheliomas","volume":"3","author":"De Luca","year":"1997","journal-title":"Nat Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-Line Nivolumab Plus Ipilimumab in Unresectable Malignant Pleural Mesothelioma (CheckMate 743): A Multicentre, Randomised, Open-Label, Phase 3 Trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.679609\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T09:18:06Z","timestamp":1624267086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.679609\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":118,"alternative-id":["10.3389\/fonc.2021.679609"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.679609","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,21]]},"article-number":"679609"}}